Interstitial lung disease

Latest News

FDA Approves Nerandomilast, First New IPF Treatment in More Than a Decade / image credit ©Waldennarus/stock.adobe.com
October 8th 2025
FDA Approves Nerandomilast, First New IPF Treatment in More Than a Decade

Approval of the novel oral PDE4B inhibitor offers hope to individuals with the rare, chronic, and progressive pulmonary disease for which treatment options are few.

The IPF Pipeline image credit IPF ©Vector Market/stock.adobe.com (AI)
September 10th 2025

The IPF Pipeline is Set to Deliver: The 3 Top Contenders

© Michael_Vi/stock.adboe.com
February 11th 2025

Nerandomilast Meets Primary Endpoint in Phase III FIBRONEER-ILD Trial in Progressive Pulmonary Fibrosis